Maria Dobek, Vice President of Accounting at Janux Therapeutics, Inc. ($JANX), made one open market sale of company shares in the last year, totaling about $20,000, with the most recent on January 2, 2026. She ranks 11,038th among 11,678 individual insiders by sale value, well below the average of $8.6 million across about 6.4 transactions per insider. Dobek had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Dobek Maria | Vice President, Accounting | S | Common Stock | 1462 | $13.73 | 15,373.0000 | 62,023,685 | 8.68% | 0.00% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Dobek Maria | Vice President, Accounting | A | Common Stock | 18935 | $0.00 | 34,308.0000 | 62,023,685 | 123.17% | 0.03% |
| Jan. 2, 2026 | Janux Therapeutics, Inc. | $JANX | Dobek Maria | Vice President, Accounting | A | Stock option (right to buy) | 42600 | $0.00 | 42,600.0000 | 62,023,685 | 9999.99% | 0.07% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | Dobek Maria | Vice President, Accounting | A | Common Stock | 14000 | $0.00 | 14,001.0000 | 53,751,480 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Janux Therapeutics, Inc. | $JANX | Dobek Maria | Vice President, Accounting | A | Stock option (right to buy) | 31500 | $0.00 | 31,500.0000 | 53,751,480 | 9999.99% | 0.06% |